EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Changes in laboratory results in transgender individuals on hormone therapy: a retrospective study and practical approach

Evelien Tm Boekhout-Berends iD, Chantal M Wiepjes, Nienke M Nota, Hans Hm Schotman, Annemieke C Heijboer, Martin den Heijer

European Journal of Endocrinology · 10.05.2023 · 188 (5) · 457-466

DOI: 10.1093/ejendo/lvad052 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Endocrinology, online erschienen am 24.05.2023. Verfasst von Evelien Tm Boekhout-Berends und 5 weiteren Autor:innen. Beteiligte Einrichtung: Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Clinical Chemistry, de Boelelaan 1117, 1081 HV Amsterdam, the Netherlands. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Interpreting laboratory results for transgender individuals who started hormone therapy requires careful consideration, specifically for analytes that have sex-specific reference intervals. In literature, conflicting data exist on the effect of hormone therapy on laboratory parameters. By studying a large cohort, we aim to define what reference category (male or female) is most appropriate to use for the transgender population over the course of gender-affirming therapy.

Methods

A total of 2201 people (1178 transgender women and 1023 transgender men) were included in this study. We analyzed hemoglobin (Hb), hematocrit (Ht), alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), gamma-glutamyltransferase (GGT), creatinine, and prolactin, at 3 different time points: pretreatment, during hormone therapy, and after gonadectomy.

Results

For transgender women, Hb and Ht levels decrease after initiation of hormone therapy. The concentration of liver enzymes ALT, AST, and ALP decreases whereas the levels of GGT do not change statistically significantly. Creatinine levels decrease whereas prolactin levels rise in transgender women during gender-affirming therapy. For transgender men, Hb and Ht values increase after starting hormone therapy. Liver enzymes and creatinine levels increase statistically significantly as well upon hormone therapy while prolactin concentrations decrease. Overall, reference intervals in transgender people after 1 year on hormone therapy resembled those of their affirmed gender.

Conclusions

Generating transgender-specific reference intervals is not essential to correctly interpret laboratory results. As a practical approach, we recommend to use the reference intervals of the affirmed gender from 1 year onwards after starting hormone therapy.

Schlagwörter

Stichwörter der Autor:innen

Transgender individualshormone therapylaboratory medicinereference intervals

Autor:innen und Institutionen

  • Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Clinical Chemistry, de Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.
  • Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Division of Endocrinology, Center of Expertise on Gender Dysphoria, de Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.
  • Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam Gastroenterology Endocrinology & Metabolism, de Boelelaan 1117, 1081 HV Amsterdam, the Netherlands.
  • Amsterdam UMC, University of Amsterdam, Department of Clinical Chemistry, Endocrine Laboratory, Amsterdam Gastroenterology Endocrinology & Metabolism, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

ORCID-Profile: Evelien Tm Boekhout-Berends

Zitieren

APA

Boekhout-Berends, E. T., Wiepjes, C. M., Nota, N. M., Schotman, H. H., Heijboer, A. C., & den Heijer, M. (2023). Changes in laboratory results in transgender individuals on hormone therapy: a retrospective study and practical approach. European Journal of Endocrinology, 188(5), 457-466. https://doi.org/10.1093/ejendo/lvad052

Vancouver

Boekhout-Berends ET, Wiepjes CM, Nota NM, Schotman HH, Heijboer AC, den Heijer M. Changes in laboratory results in transgender individuals on hormone therapy: a retrospective study and practical approach. European Journal of Endocrinology. 2023;188(5):457-466. doi:10.1093/ejendo/lvad052

BibTeX
@article{BoekhoutBerends2023,
  author = {Boekhout-Berends, Evelien Tm and Wiepjes, Chantal M and Nota, Nienke M and Schotman, Hans Hm and Heijboer, Annemieke C and den Heijer, Martin},
  title = {Changes in laboratory results in transgender individuals on hormone therapy: a retrospective study and practical approach},
  journal = {European Journal of Endocrinology},
  year = {2023},
  volume = {188},
  number = {5},
  pages = {457--466},
  doi = {10.1093/ejendo/lvad052}
}
Kostenlos starten →